About Gopal Das
Form D filings for 2A Biosciences in 2023 list Gopal Das as director.
Gopal Das first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Gopal Das in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Gopal Das works with at each company, as listed on that company's latest Form D.
2A Biosciences, Inc. · Form D/A, Jul 27, 2023
AS
Alexander Speiser
Chief Executive Officer and director
CN
Charles Nichols
Chief Scientific Officer and director
TF
Timothy Foster
Head of Research and director
DN
David Nichols
Chief Drug Discovery Officer and director